Pasithea Therapeutics Corp Warrant

Yahoo Finance • 5 months ago

Pasithea Therapeutics 3.57M share Secondary priced at $1.40

The gross proceeds to the company from the offering are expected to be approximately $5M, before deducting the placement agent’s fees and other offering expenses payable by the company. The company intends to use the net proceeds from this... Full story